13
DCAT Week returned to New York City in full glory last month, with the Drug, Chemical & Associated Technologies (DCAT) Association’s first post-COVID event for companies engaged in the bio/pharmaceutical manufacturing value chain. There was tremendous excitement surrounding the private, high-level, strategic meetings that facilitate the development of global networks, and which allow the industry’s C-suites to keep pace with the ever-changing bio/pharmaceutical markets.
Login now to read the full article
Don’t have an account yet? Subscribe now, it’s free!
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.
All pubblications
archive from 2022 to today
All articles
PDF Version
Receive our latest issue alerts
directly to your mailbox